The cobas® 6800/8800 System: a new era of automation in molecular diagnostics

References

• Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987;155:335–350.
   PubMed Web of Science ®Google Scholar
• Saiki RK, Bugawan TL, Horn GT, et al. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature. 1986;324(6093):163–166.
   PubMed Web of Science ®Google Scholar
• Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239(4839):5.
   Web of Science ®Google Scholar
• Mullis KB. The unusual origin of the polymerase chain reaction. Sci Am. 1990;262(4):56-61, 64-55.
   PubMed Web of Science ®Google Scholar
• Mullis KB. Target amplification for DNA analysis by the polymerase chain reaction. Ann Biol Clin (Paris). 1990;48(8):579–582.
   PubMed Web of Science ®Google Scholar
• Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature. 1970;226(5252):1209–1211.
   PubMed Web of Science ®Google Scholar
• Myers TW, Gelfand DH. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry. 1991;30(31):7661–7666.
   PubMed Web of Science ®Google Scholar
• Birch DE. Simplified hot start PCR. Nature. 1996;381(6581):445–446.
   PubMed Web of Science ®Google Scholar
• Savva R, McAuley-Hecht K, Brown T, et al. The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature. 1995;373(6514):487–493.
   PubMed Web of Science ®Google Scholar
• Mol CD, Arvai AS, Slupphaug G, et al. Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell. 1995;80(6):869–878.
   PubMed Web of Science ®Google Scholar
• Prevention CfDCa. Biosafety in microbiological and biomedical laboratories, 5th ed. (ed. Department of Health and Human Services, PHS). Bethesda, Maryland: National Institutes of Health; 2009.
   Google Scholar
• Holland PM, Abramson RD, Watson R, et al. Detection of specific polymerase chain reaction product by utilizing the 5ʹ-3ʹ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88(16):7276–7280.
   PubMed Web of Science ®Google Scholar
• Grimberg J, Nawoschik S, Belluscio L, et al. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res. 1989;17(20):8390.
   PubMed Web of Science ®Google Scholar
• Boom R, Sol CJ, Salimans MM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28(3):495–503.
   PubMed Web of Science ®Google Scholar
• Padhye VV, York C, Burkiewiez A. ‘Nucleic acid purification on silica gel and glass mixture.’ United States patent US 5658548, Promega Corporation, Madison WI, August, 1997.
   Google Scholar
• Woodard DL, Howard AJ, Down JA. ‘Process for purifying DNA on hydrated silica.’ United States patent US 5342931, Becton, Dickinson and Company, Franklin Lakes, NJ, August 1994.
   Google Scholar
• Stelzl E, Kormann-Klement A, Haas J, et al. Evaluation of an automated sample preparation protocol for quantitative detection of hepatitis C virus RNA. J Clin Microbiol. 2002;40(4):1447–1450.
   PubMed Web of Science ®Google Scholar
• Sloma CR, Germer JJ, Gerads TM, et al. Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs. J Clin Microbiol. 2009;47(4):889–895.
   PubMed Web of Science ®Google Scholar
• Schumacher W, Frick E, Kauselmann M, et al. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol. 2007;38(4):304–312.
   PubMed Web of Science ®Google Scholar
• Streitberg GS, Angel L, Sikaris KA, et al. Automation in clinical biochemistry: core, peripheral, STAT, and specialist laboratories in Australia. J Lab Autom. 2012;17(5):387–394.
   PubMedGoogle Scholar
• Armbruster DA, Overcash DR, Reyes J. Clinical chemistry laboratory automation in the 21st century – Amat Victoria curam (Victory loves careful preparation). Clin Biochemist. 2014;35(3):143–153.
   PubMedGoogle Scholar
• Zaninotto M, Plebani M. The ‘hospital central laboratory’: automation, integration and clinical usefulness. Clin Chem Lab Med. 2010;48(7):911–917.
   PubMed Web of Science ®Google Scholar
• Hawker CD. Laboratory automation: total and subtotal. Clin Lab Med. 2007;27(4):749–770, vi.
   PubMed Web of Science ®Google Scholar
• Ledeboer NA, Dallas SD. The automated clinical microbiology laboratory: fact or fantasy? J Clin Microbiol. 2014;52(9):3140–3146.
   PubMed Web of Science ®Google Scholar
• Khiri H, Camus C, Portugal M, et al. [Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France]. Ann Biol Clin (Paris). 2014;72(2):213–223.
   PubMed Web of Science ®Google Scholar
• Burnham CA, Dunne WM Jr., Greub G, et al. Automation in the clinical microbiology laboratory. Clin Chem. 1696-1702;59(12):2013.
   Web of Science ®Google Scholar
• A. P. Labs weighing pros, cons of micro TLA. Today. January 2014.
   Google Scholar
• Gallagher LM, Ganz PR, Yang H, et al. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop. Transfusion. 2013;53(2):455–463.
   PubMed Web of Science ®Google Scholar
• Stramer SL. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Science Series. 2014;9(1):30–36.
   PubMedGoogle Scholar
• Melanson SE, Lindeman NI, Jarolim P. Selecting automation for the clinical chemistry laboratory. Arch Pathol Lab Med. 2007;131(7):1063–1069.
   PubMed Web of Science ®Google Scholar
• Amendola A, Coen S, Belladonna S, et al. Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA. Clin Chem Lab Med. 2011;49(8):1283–1288.
   PubMed Web of Science ®Google Scholar
• Ratnam S, Jang D, Gilchrist J, et al. Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections. J Clin Microbiol. 2014;52(7):2299–2304.
   PubMed Web of Science ®Google Scholar
• Novak SM, Marlowe EM. Automation in the clinical microbiology laboratory. Clin Lab Med. 2013;33(3):567–588.
   PubMed Web of Science ®Google Scholar
• Coles CbLCo. Report of the review of NHS pathology services in England: an independent review for the department of health. health, cftdo. London: DH Publications Orderline. 2006. p. 1–87.
   Google Scholar
• Udaykumar J, Epstein JS, Hewlett IK. A novel method employing UNG to avoid carry-over contamination in RNA-PCR. Nucleic Acids Res. 1993;21(16):3917–3918.
   PubMed Web of Science ®Google Scholar
• Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346(6287):818–822.
   PubMed Web of Science ®Google Scholar
• Bauer KA, Fiss E, Gelfand DH, et al. DNA polymerases and related methods. United States patent US 20110294168 A1, Roche Molecular Systems, Inc. Pleasanton, CA, December, 2011.
   Google Scholar
• Griffin L, Albrecht G, Latham J, et al. Aptamers specific for biomolecules and methods of making. United States patent, US 5756291 A, Gilead Sciences, Inc., Foster City, CA, May, 1998.
   Google Scholar
• Gilligan PH. Impact of clinical practice guidelines on the clinical microbiology laboratory. J Clin Microbiol. 2004;42(4):1391–1395.
   PubMed Web of Science ®Google Scholar
• Woolf SH, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. Bmj. 1999;318(7182):527–530.
   PubMed Web of Science ®Google Scholar
• CBER. Draft guidance for industry, Food and Drug Administration staff, and clinical laboratories framework for regulatory oversight of laboratory developed tests (LDTs). 10903 New Hampshire Ave., Bldg. 71, rm. 3128, Silver Spring, MD:Services, USDoHaH (Ed.^(Eds) (Food and Drug Administration); 2014. 20993–0002. This document describes a risk-based framework for addressing the regulatory oversight of a subset of in vitro diagnostic devices1 (IVDs) referred to as laboratory developed tests (LDTs).
   Google Scholar
• Haug CJ, Kieny MP, Murgue B. The Zika challenge. N Engl J Med. 2016;374(19):1801–1803.
   PubMed Web of Science ®Google Scholar
• Marks PW, Epstein JS, Borio LL. Maintaining a safe blood supply in an era of emerging pathogens. J Infect Dis. 2016;213(11):1676–1677.
   PubMed Web of Science ®Google Scholar
• Towner JS, Sealy TK, Ksiazek TG, et al. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 2007;196(Suppl 2):S205–212.
   PubMed Web of Science ®Google Scholar
• U.S. Food & Drug Administration. FDA allows use of investigational test to screen blood donations for Zika virus. Use of investigational test 860 allows blood establishments in Puerto Rico to resume collecting whole blood and blood component donations. Silver Spring (MD): Food & Drug Administration. 2016. [cited 2016 Apr 19].  Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm493081.htm
   Google Scholar
• World Health Organization. Abbreviated pre-qualification assessment: WHO prequalification of in vitro diagnostics programme. The programme aims to promote and facilitate access to safe, appropriate and affordable in vitro diagnostics of good quality in an equitable manner. Focus is placed on in vitro diagnostics for priority diseases and their suitability for use in resource-limited settings. Geneva: World Health Organization. [cited 2014 May]. Available from: http://www.who.int/diagnostics_laboratory/evaluations/140530_pqdx_173_abbreviated_assessment_v1_final_buffet.pdf?ua=1
   Google Scholar
• Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(Suppl 3):S139–170.
   PubMed Web of Science ®Google Scholar